Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Brca Null'

Brca Null published presentations and documents on DocSlides.

Lynch Syndrome and BRCA 1/2
Lynch Syndrome and BRCA 1/2
by yoshiko-marsland
21 yo female px to GP with 3/52 of severe abdomin...
56 th
56 th
by liane-varnes
Annual Ob-Gyn Update. Ovarian Cancer:. Finally. ...
Case Discussion: Second
Case Discussion: Second
by celsa-spraggs
Opinion. 55 year-old woman with . recurrent . ova...
Patient Selection for PARP
Patient Selection for PARP
by sherrill-nordquist
Inhibitors:. Purpose and Practicalities . Present...
Please note, these are the actual video-recorded
Please note, these are the actual video-recorded
by blindnessinfluenced
proceedings from the live CME event and may includ...
TheXevaUsersGuideArvindMer12andBenjaminHaibeKains123451Princess
TheXevaUsersGuideArvindMer12andBenjaminHaibeKains123451Princess
by isla
TheXevaUser'sGuide1Introduction TheXevapackageprov...
Clinical Cancer Genetics in
Clinical Cancer Genetics in
by luna
Breast and Ovarian Cancers. The Role of Cancer Gen...
CARCINOMA (BRCA) LEC 2 Dr.Eaman
CARCINOMA (BRCA) LEC 2 Dr.Eaman
by lily
. suud. . khalifa. Learning objectives:. Discuss ...
Hereditary syndromes, genetic testing and
Hereditary syndromes, genetic testing and
by Kingslayer
gynaecological. cancers. Prof.. Nicoletta . Col...
ACC ACC BLCA BLCA BRCA BRCA
ACC ACC BLCA BLCA BRCA BRCA
by hadly
CESC. CESC. CHOL. CHOL. COAD. COAD. DLCB. DLCB. ES...
Why and how to test for germline
Why and how to test for germline
by isabella2
BRCA. mutations in Pancreatic Cancer. ESDO Learni...
NonBreast / NonOvarian BRCA1/2 related neoplasms: a growing entity
NonBreast / NonOvarian BRCA1/2 related neoplasms: a growing entity
by skylar
Laura Cortesi. BRCA1/2 Mutations: Cancer Risks. BR...
Supplementary data Identication of novel intronic BRCA
Supplementary data Identication of novel intronic BRCA
by tatyana-admore
Genet 90 327331 Table 1 Oligodeoxyribonucleotide...
Ovarian cancer
Ovarian cancer
by myesha-ticknor
Talking point:. Genetics of ovarian cancer. 49F. ...
Yolanda Lawson M.D., F.A.C.O.G
Yolanda Lawson M.D., F.A.C.O.G
by lindy-dunigan
MadeWell OBGYN. Associate Attending . Baylor Univ...
PCR Application:
PCR Application:
by alexa-scheidler
Can Breast Cancer be Cured?. Normal, Healthy Cell...
Breast Cancer Screening and Diagnosis
Breast Cancer Screening and Diagnosis
by yoshiko-marsland
Dr. Ruth . Heisey. Family Physician/GP Oncologist...
Heredity Tidbit
Heredity Tidbit
by lindy-dunigan
Participants: Facilitator:. Virginia . Carson ...
How to find a breast surgeon
How to find a breast surgeon
by pamella-moone
And why you would want to. …... To serve our p...
Detection of Hereditary Breast Cancer
Detection of Hereditary Breast Cancer
by faustina-dinatale
Breast Cancer Genes. Two genes associated with in...
Elizabeth Kent MD Medical Oncology/Hematology
Elizabeth Kent MD Medical Oncology/Hematology
by test
May 19, 2017. Hereditary Cancer Syndromes. Recogn...
Growth Patterns and Pathobiology of Experimental and
Growth Patterns and Pathobiology of Experimental and
by pamella-moone
Clinical Malignancies. In Vivo. Updated: March . ...
State of the Art in BRCA
State of the Art in BRCA
by ellena-manuel
-Mutated Ovarian Cancer. This program will includ...
Breast & Ovarian Cancer:
Breast & Ovarian Cancer:
by faustina-dinatale
BRCA1 and BRCA2. Jennifer . Hardee. Normal functi...
Cancer Chemotherapy Part I: General Cancer Chemotherapy
Cancer Chemotherapy Part I: General Cancer Chemotherapy
by ellena-manuel
Chapter 16; Pages 797 to 815A. also Section 16.11...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
Preventive Screenings at no cost to you
Preventive Screenings at no cost to you
by jane-oiler
Covered at 100% in-network, not subject to deduct...
Novel Strategies in the Management of Progressive
Novel Strategies in the Management of Progressive
by calandra-battersby
BRCA. -Mutated Breast Cancer. This program will i...
The Nurse View: Clinical Considerations in the Management of
The Nurse View: Clinical Considerations in the Management of
by natalia-silvester
BRCA. -Mutated Advanced Ovarian Cancer. Moderator...
Breast & Ovarian Cancer:
Breast & Ovarian Cancer:
by debby-jeon
BRCA1 and BRCA2. Jennifer . Hardee. Normal functi...
1. In general, when do you typically order mutation testing for your patients with newly diagnosed
1. In general, when do you typically order mutation testing for your patients with newly diagnosed
by opelogen
At initial diagnosis . 0. At first relapse . 0. At...
by medshair
Five-year . survival. 15%. 30%. 40%. ?50%?. First ...
Ovarian Cancer: Standards of Care and New Opportunities
Ovarian Cancer: Standards of Care and New Opportunities
by majerepr
Robert L. Coleman, M.D.. Professor & . Vice Ch...
Overview of BRCA1 and
Overview of BRCA1 and
by ashley
BRCA2. What we know so far. Dr Helen Hanson and Dr...
BREAST PATHOLOGY LEC. 1
BREAST PATHOLOGY LEC. 1
by oconnor
. 2. TUMORS OF THE BREAST. Fibroadenoma. . Is the...
Genetic testing in ovarian cancer
Genetic testing in ovarian cancer
by BlueEyedBeauty
Dr Katie Snape. Joint Lead Consultant for Cancer G...
Looking ahead: Genomic Laboratory Hub
Looking ahead: Genomic Laboratory Hub
by LaughsALot
Rachel Butler, Head of Bristol Genetics Laboratory...
Genetic Testing for BRCA1 and BRCA2 Inform
Genetic Testing for BRCA1 and BRCA2 Inform
by barbara
How common are BRCA1 and BRCA2 mutations in the ge...
DISORDERSETTING
DISORDERSETTING
by rose
Question 1: What is the specific clinical disorder...
Ovarian Cancer Risk, Screening and Surgery
Ovarian Cancer Risk, Screening and Surgery
by amber
Stuart Salfinger. Gynaecologic Oncologist. MBBS, F...